Date Posted: 2011-09-06 12:41 New Issue: Port Erin Biopharma Investments Limited Based in the Isle of Man, Port Erin was formed on 3 May 2011 as an Investing Company to invest in the biotechnology and biopharmaceutical sector.
The Company's strategy is to create value for Shareholders through investing in companies that have the potential to generate substantial revenues through the development of biopharmaceutical drugs. The Directors intend to focus on investing in biotechnology and biopharmaceutical companies operating on the West Coast of the United States of America, where many biotech companies are based. Port Erin has been established as a publicly traded investing company which will offer Shareholders an opportunity to participate in opportunities in the biotechnology and biopharmaceutical sector.
Listing exchange: AIM
Expected first day of trading: 2011-09-12
Expected money raised: £3M Any information, prospectus or other document, or any hypertext link to any of the aforesaid should not be construed as advice on investments or a personal recommendation by ALL IPO plc and is being offered on an execution-only basis. Any decision to invest should be made only after careful consideration of the relevant documentation and particularly after acceptance of the full terms and conditions relating to the specific investment opportunity. Share prices, values and income can go down as well as up and you may get back less than the amount you invested. If in doubt about the suitability of investments referred to in this communication and on our website, you should consult an investment adviser authorised under the Financial Services and Markets Act 2000. | 